Allbiotech has developed the Genesys V1 laboratory bioreactor to make controlled fermentation more accessible to companies in the food industry.

The most precise fermentation within everyone’s reach

The Spanish company Allbiotech has developed Genesys V1, a laboratory bioreactor designed to facilitate access to controlled fermentation whilst maintaining a high degree of operational versatility. In doing so, it addresses one of the main barriers food companies face when moving from flask-scale experiments to controlled processes.

Allbiotech’s approach is based on the premise of making bioprocesses accessible by reducing the investment required to acquire a bioreactor, without sacrificing key functionalities for research and development in biotechnology.

The Genesys V1 has been designed as a flexible platform for working with different cultivation strategies and experimental requirements. The system incorporates five peristaltic pumps, enabling the automation of routine fermentation tasks such as pH control via the addition of acid and base, the dosing of antifoaming agents, or the feeding of cultures in fed-batch processes.

The reactor lid features seven inlet and outlet ports, designed for operations such as adding reagents, feeding the culture, sampling, venting gases, or filling and draining the system. In addition, there are four specific ports for sensors compatible with Hamilton technology, one of which is dedicated to the proprietary foam control system developed by Allbiotech.

This system uses ultrasound to detect foam formation, which automatically triggers the addition of defoamer when necessary, thereby preventing common problems in microbial fermentation.

The equipment is managed via intuitive control software, which allows operation in manual, automatic or programmed modes, as well as offering remote access to monitor and adjust the process in real time.